Author

Xiling Guo

Jiangsu Provincial Center for Disease Control and Prevention

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Chengliang Hu· 1 shared Chunhao YangiD· 1 shared Dan Yang ZhaoiD· 1 shared Enming YuaniD· 1 shared Fang WaniD· 1 shared Fengcai ZhuiD· 1 shared Hainian Zeng· 1 shared Haitao LiiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Chengliang Hu

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

Yiyue Ge, Tingzhong Tian, Suling Huang, Fang Wan, Jingxin Li, Shuya Li, Xiaoting Wang, Hui Mei Yang, Lixiang Hong, Nian Wu, Enming Yuan, Yunan Luo, Lili Cheng, Chengliang Hu, Yipin Lei, , Jianyang Zeng

This paper presents a data-driven drug repositioning framework that identifies CVL218, a PARP1 inhibitor, as a potential therapeutic for COVID-19 through in silico and experimental validation.

Signal Transduction and Targeted Therapy · Apr 24, 2021Peer-reviewedSystems Biology